Free Trial

Kintara Therapeutics (KTRA) Earnings Date, Estimates & Call Transcripts

$0.15
-0.02 (-14.00%)
(As of 09:46 AM ET)

Earnings Summary

Upcoming
Earnings Date
Sep. 16Estimated
Actual EPS
(Feb. 14)
-$0.24 Missed By -$0.24
Skip Charts & View Estimated and Actual Earnings Data

KTRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KTRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

KTRA Earnings Date and Information

Kintara Therapeutics last announced its earnings data on February 14th, 2024. The reported ($0.24) earnings per share (EPS) for the quarter. Kintara Therapeutics has generated ($4.07) earnings per share over the last year (($4.07) diluted earnings per share). Kintara Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 16th, 2024 based off prior year's report dates.

Kintara Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
9/16/2024
(Estimated)
------- 
2/14/2024Q2 2024-($0.24)($0.24)($0.24)--
11/13/2023Q1 2024-($1.83)($1.83)($1.83)--
9/18/2023Q4 2023($0.18)($1.95)($1.77)($1.95)--
5/11/2023Q3 2023($0.10)($1.94)($1.84)($1.94)--
2/14/2023Q2 2023($2.80)($2.10)+$0.70($2.10)--
11/9/2022Q1 2023-($3.50)($3.50)($0.07)--
9/27/2022Q4 2022($1.50)($3.50)($2.00)($0.07)--
5/13/2022Q3 2022($5.50)($5.50)-($0.11)--
2/11/2022Q2 2022($9.00)($6.00)+$3.00($0.12)--    
11/15/2021Q3 2021($7.00)($8.50)($1.50)($0.25)--
9/28/2021Q2 2021($8.00)($6.50)+$1.50($0.13)--
5/14/2021Q1 2021($9.00)($11.50)($2.50)($0.23)--
2/11/2021Q4 2020($7.00)($11.00)($4.00)($0.22)--
11/13/2020Q1 2021($1.50)($19.50)($18.00)$0.55--
9/21/2020Q4 2020($4.50)($12.50)($8.00)($0.15)--
5/13/2020Q3 2020($2.50)($8.50)($6.00)($0.17)--
5/13/2020Q1 2020($5.50)($8.50)($3.00)($0.17)--
2/13/2020Q2 2020-($7.50)($7.50)($0.15)--
2/13/2020Q2($8.75)($7.50)+$1.25($0.15)--
11/13/2019Q1 2020($20.00)($10.50)+$9.50($0.21)--
11/13/2019Q1 2020($20.00)($10.50)+$9.50($0.21)--
9/10/2019Q4 2019($15.00)($44.50)($29.50)($0.89)--
9/10/2019Q4 2019($15.00)($44.50)($29.50)($0.89)--

Kintara Therapeutics Earnings - Frequently Asked Questions

When is Kintara Therapeutics's earnings date?

Kintara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 16th, 2024 based off last year's report dates. Learn more on KTRA's earnings history.

How much profit does Kintara Therapeutics generate each year?

Kintara Therapeutics (NASDAQ:KTRA) has a recorded net income of -$14.65 million. KTRA has generated -$4.07 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:KTRA) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners